Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4-Reference-Cited by-同舟云学术

Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4

Published:2020-07-08 Issue:3 Volume:57 Page:780-790
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Jiang Zhongmin¹,Zhang Chunyan²,Liu Xiaozhi³,Ma Xiaofang³,Bian Xiyun ³,Xiao Xiaolin³,Gao Rui³,Sun Yajing⁴,Wu Wenhan³,Zhao Po⁵

Affiliation:

1. Department of Pathology, Chinese People's Liberation Army (PLA) General Hospital, Beijing 100853, P.R. China

2. Department of Pharmacy, Binhai New Area Hospital of Traditional Chinese Medicine, Tianjin 300450, P.R. China

3. Tianjin Key Laboratory of Epigenetics for Organ Development in Preterm Infants, The Fifth Central Hospital of Tianjin, Tianjin 300450, P.R. China

4. Department of Pathology, The Fifth Central Hospital of Tianjin, Tianjin 300450, P.R. China

5. Department of Pathology, Chinese People's Liberation Army (PLA) General Hospital, Beijing 100853, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemistry of Genus Buxus and Pharmacology of Cyclovirobuxine D;Chemistry & Biodiversity;2024-07-03

2. Dexamethasone–tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells;Bioscience Reports;2024-07

3. Abnormal protein SUMOylation in liver disease: novel target for therapy;Journal of Molecular Medicine;2024-04-03

4. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer;Experimental Cell Research;2023-04

5. Self-nanoemulsifying drug delivery systems (SNEDDS) of anti-cancer drugs: a multifaceted nanoplatform for the enhancement of oral bioavailability;Drug Development and Industrial Pharmacy;2023-01-02